Hannappe, M.-A.; Baudin, F.; Mariet, A.-S.; Gabrielle, P.-H.; Arnould, L.; Bron, A.M.; Creuzot-Garcher, C.
Mid-Term Impact of Anti-Vascular Endothelial Growth Factor Agents on Intraocular Pressure. J. Clin. Med. 2022, 11, 946.
https://doi.org/10.3390/jcm11040946
AMA Style
Hannappe M-A, Baudin F, Mariet A-S, Gabrielle P-H, Arnould L, Bron AM, Creuzot-Garcher C.
Mid-Term Impact of Anti-Vascular Endothelial Growth Factor Agents on Intraocular Pressure. Journal of Clinical Medicine. 2022; 11(4):946.
https://doi.org/10.3390/jcm11040946
Chicago/Turabian Style
Hannappe, Marc-Antoine, Florian Baudin, Anne-Sophie Mariet, Pierre-Henri Gabrielle, Louis Arnould, Alain M. Bron, and Catherine Creuzot-Garcher.
2022. "Mid-Term Impact of Anti-Vascular Endothelial Growth Factor Agents on Intraocular Pressure" Journal of Clinical Medicine 11, no. 4: 946.
https://doi.org/10.3390/jcm11040946
APA Style
Hannappe, M.-A., Baudin, F., Mariet, A.-S., Gabrielle, P.-H., Arnould, L., Bron, A. M., & Creuzot-Garcher, C.
(2022). Mid-Term Impact of Anti-Vascular Endothelial Growth Factor Agents on Intraocular Pressure. Journal of Clinical Medicine, 11(4), 946.
https://doi.org/10.3390/jcm11040946